Cargando…
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
Serum levels of cartilage oligomeric matrix protein (COMP) has been presented as a biomarker of liver fibrosis in several cross-sectional studies. COMP is also an essential mediator in carcinoma development and has also been associated with hepatocellular carcinoma. We present a prospective analysis...
Autores principales: | Andréasson, Kristofer, Jönsson, Göran, Hesselstrand, Roger, Norrgren, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447423/ https://www.ncbi.nlm.nih.gov/pubmed/30967910 http://dx.doi.org/10.4254/wjh.v11.i3.330 |
Ejemplares similares
-
Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
por: Otteby, Kaisa E, et al.
Publicado: (2013) -
Cartilage Oligomeric Matrix Protein in Idiopathic Pulmonary Fibrosis
por: Vuga, Louis J., et al.
Publicado: (2013) -
Absence of fibromodulin affects matrix composition, collagen deposition and cell turnover in healthy and fibrotic lung parenchyma
por: Rydell-Törmänen, Kristina, et al.
Publicado: (2014) -
Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019) -
Elevated Levels of Cartilage Oligomeric Matrix Protein during In Vitro Cartilage Matrix Generation Decrease Collagen Fibril Diameter
por: Bastiaansen-Jenniskens, Y.M., et al.
Publicado: (2010)